Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 15 studies | 27% ± 10% | |
astrocyte | 10 studies | 34% ± 17% | |
glutamatergic neuron | 9 studies | 40% ± 27% | |
oligodendrocyte | 9 studies | 30% ± 11% | |
oligodendrocyte precursor cell | 9 studies | 30% ± 14% | |
fibroblast | 8 studies | 24% ± 7% | |
GABAergic neuron | 8 studies | 40% ± 23% | |
macrophage | 7 studies | 25% ± 6% | |
epithelial cell | 7 studies | 36% ± 13% | |
adipocyte | 7 studies | 25% ± 6% | |
interneuron | 6 studies | 41% ± 24% | |
microglial cell | 6 studies | 25% ± 7% | |
retina horizontal cell | 6 studies | 27% ± 9% | |
retinal rod cell | 6 studies | 20% ± 3% | |
ciliated cell | 6 studies | 23% ± 7% | |
neuron | 5 studies | 31% ± 13% | |
amacrine cell | 5 studies | 26% ± 9% | |
goblet cell | 5 studies | 27% ± 18% | |
pericyte | 5 studies | 21% ± 6% | |
retinal cone cell | 4 studies | 32% ± 10% | |
cardiac muscle cell | 4 studies | 23% ± 1% | |
type I pneumocyte | 4 studies | 21% ± 6% | |
type II pneumocyte | 4 studies | 20% ± 4% | |
connective tissue cell | 4 studies | 18% ± 1% | |
monocyte | 4 studies | 18% ± 1% | |
endothelial cell of lymphatic vessel | 4 studies | 22% ± 3% | |
GABAergic interneuron | 3 studies | 23% ± 3% | |
granule cell | 3 studies | 20% ± 5% | |
retinal ganglion cell | 3 studies | 40% ± 10% | |
Mueller cell | 3 studies | 21% ± 5% | |
glycinergic amacrine cell | 3 studies | 23% ± 4% | |
rod bipolar cell | 3 studies | 24% ± 5% | |
hepatocyte | 3 studies | 34% ± 17% | |
dendritic cell | 3 studies | 20% ± 5% | |
abnormal cell | 3 studies | 26% ± 8% | |
club cell | 3 studies | 23% ± 6% | |
lymphocyte | 3 studies | 20% ± 5% | |
basal cell | 3 studies | 36% ± 14% | |
transit amplifying cell | 3 studies | 33% ± 21% | |
smooth muscle cell | 3 studies | 21% ± 1% | |
mast cell | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2870.04 | 1445 / 1445 | 100% | 28.02 | 183 / 183 |
lung | 100% | 3022.58 | 578 / 578 | 100% | 31.91 | 1155 / 1155 |
ovary | 100% | 3483.25 | 180 / 180 | 100% | 27.69 | 430 / 430 |
pancreas | 100% | 2101.21 | 328 / 328 | 100% | 29.84 | 178 / 178 |
prostate | 100% | 3355.20 | 245 / 245 | 100% | 51.38 | 502 / 502 |
brain | 100% | 4694.66 | 2641 / 2642 | 100% | 49.82 | 705 / 705 |
breast | 100% | 3181.97 | 459 / 459 | 100% | 45.25 | 1116 / 1118 |
intestine | 100% | 3152.42 | 966 / 966 | 100% | 33.81 | 525 / 527 |
thymus | 100% | 3784.00 | 653 / 653 | 100% | 36.55 | 602 / 605 |
uterus | 100% | 3325.47 | 170 / 170 | 99% | 26.20 | 456 / 459 |
stomach | 100% | 2695.58 | 359 / 359 | 99% | 30.23 | 284 / 286 |
kidney | 100% | 5008.99 | 89 / 89 | 99% | 39.37 | 894 / 901 |
adrenal gland | 100% | 4444.66 | 258 / 258 | 99% | 42.84 | 228 / 230 |
bladder | 100% | 3013.52 | 21 / 21 | 99% | 27.89 | 499 / 504 |
skin | 100% | 3593.79 | 1808 / 1809 | 96% | 32.79 | 455 / 472 |
liver | 100% | 1691.42 | 226 / 226 | 96% | 16.70 | 388 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 17.97 | 29 / 29 |
spleen | 100% | 2172.24 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 25.74 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.57 | 1 / 1 |
blood vessel | 100% | 3185.90 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 2980.90 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 2836.10 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 3474.67 | 831 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 21.67 | 76 / 80 |
peripheral blood | 51% | 1275.83 | 471 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006289 | Biological process | nucleotide-excision repair |
GO_0010821 | Biological process | regulation of mitochondrion organization |
GO_0071577 | Biological process | zinc ion transmembrane transport |
GO_0006882 | Biological process | intracellular zinc ion homeostasis |
GO_0006829 | Biological process | zinc ion transport |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005634 | Cellular component | nucleus |
GO_0005385 | Molecular function | zinc ion transmembrane transporter activity |
GO_0015297 | Molecular function | antiporter activity |
GO_0016922 | Molecular function | nuclear receptor binding |
GO_0030374 | Molecular function | nuclear receptor coactivator activity |
GO_0003682 | Molecular function | chromatin binding |
Gene name | SLC30A9 |
Protein name | Solute carrier family 30 member 9 Proton-coupled zinc antiporter SLC30A9, mitochondrial (Human embryonic lung protein) (HuEL) (Solute carrier family 30 member 9) (Zinc transporter 9) (ZnT-9) Proton-coupled zinc antiporter SLC30A9, mitochondrial (Solute carrier family 30 member 9) (Zinc transporter 9) |
Synonyms | HUEL C4orf1 |
Description | FUNCTION: Mitochondrial proton-coupled zinc ion antiporter mediating the export of zinc from the mitochondria and involved in zinc homeostasis, zinc mobilization as well as mitochondrial morphology and health . In nucleus, functions as a secondary coactivator for nuclear receptors by cooperating with p160 coactivators subtypes. Plays a role in transcriptional activation of Wnt-responsive genes (By similarity). . |
Accessions | D6R9M6 ENST00000264451.12 A0A0S2Z512 A0A0S2Z514 ENST00000513699.5 Q6PML9 |